Accelevation Holdings
ACCV
9.58
-1.51
-13.62%
Accelevation Holdings
US · ACCV
#2771 by market cap
Listed 2026
9.58
-1.51
-13.62%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.24, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 2 years
Latest year +146.94% YoY
Margins
- Gross margin
- 32.31%
- Operating margin
- -11.44%
- Net margin
- -5.29%
Key ratios & quality
- Enterprise valuei
- 1.41B
- Altman Z-Scorei
- 2.24
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2024 | 2025 |
|---|---|---|
| Revenue | 181.35M | 447.82M |
| Gross profit | 58.86M | 144.70M |
| Selling & admin expenses | 32.80M | 161.70M |
| Research & development | -- | -- |
| Operating profit | 18.46M | -51.23M |
| Pretax profit | 9.74M | -60.14M |
| Tax | 326.00K | -8.24M |
| Net profit | 9.41M | -51.89M |
| Basic EPS | 0 | 0 |
| Diluted EPS | 0.08 | -0.23 |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Revenue | 57.82M | 100.81M | 255.99M | 181.47M |
| Gross profit | 21.29M | 27.01M | 67.76M | 48.39M |
| Selling & admin expenses | 16.02M | 6.41M | 25.40M | 36.21M |
| Research & development | -- | -- | -- | -- |
| Operating profit | -2.71M | 12.31M | 31.09M | -664.00K |
| Pretax profit | -8.23M | -168.00K | 22.23M | -998.00K |
| Tax | 136.00K | 173.00K | 460.00K | 2.45M |
| Net profit | -8.37M | -341.00K | 21.77M | -3.45M |
| Basic EPS | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.07 | 0.00 | 0.18 | -0.11 |
Balance sheet
| Line item | 2024 | 2025 |
|---|---|---|
| Total current assets | 82.56M | 210.66M |
| Cash & ST investments | 10.93M | 16.27M |
| Inventory | 9.78M | 45.29M |
| Total assets | 189.72M | 722.95M |
| Total current liabilities | 53.65M | 113.82M |
| Short-term debt | 3.39M | 5.50M |
| Long-term debt | 81.81M | 269.87M |
| Total liabilities | 149,292,000.00 | 415,788,000.00 |
| Total equity | 40.43M | 307.16M |
| Retained earnings | 113.00K | 17.82M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Total current assets | -- | -- | 318.47M | 288.23M |
| Cash & ST investments | -- | -- | 66.04M | 19.29M |
| Inventory | -- | -- | 33.77M | 38.02M |
| Total assets | -- | -- | 824.28M | 868.24M |
| Total current liabilities | -- | -- | 161.30M | 120.31M |
| Short-term debt | -- | -- | 6.04M | 9.83M |
| Long-term debt | -- | -- | 318.49M | 473.79M |
| Total liabilities | -- | -- | 511,982,000.00 | 708,630,000.00 |
| Total equity | -- | -- | 312.29M | 159.61M |
| Retained earnings | -- | -- | 39.42M | -35.57M |
Cash flow
| Line item | 2024 | 2025 |
|---|---|---|
| Operating cash flow | 10.75M | -7.22M |
| Depreciation & amortization | 7.99M | 34.81M |
| Free cash flow | 6.48M | -16.39M |
| Dividends paid | -3.56M | -19.40M |
| Stock buybacks / issuance | -6.59M | 214.42M |
| Ending cash balance | 10.93M | 16.27M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Operating cash flow | -7.96M | 3.03M | 8.89M | -13.14M |
| Depreciation & amortization | 8.07M | 8.24M | 9.67M | 9.40M |
| Free cash flow | -8.98M | -1.74M | 6.05M | -21.83M |
| Dividends paid | -753.00K | -12.56M | -4.59M | -208.79M |
| Stock buybacks / issuance | 215.00M | -330.00K | -270.00K | 0 |
| Ending cash balance | 10.23M | 11.22M | 66.04M | 161.63M |
Returns & efficiency
| Line item | 2024 | 2025 |
|---|---|---|
| ROE %i | 23.27 | -13.86 |
| ROA %i | 4.96 | -5.19 |
| ROIC %i | 13.77 | -4.10 |
| 5-year avg ROE %i | -- | -- |
| EBIT margin %i | 10.57 | -11.34 |
| FCF / sales %i | 3.57 | -- |
| Current ratioi | 1.54 | 1.85 |
| Quick ratioi | 1.30 | 1.33 |
| Debt / assetsi | 49.62 | 41.10 |
| LT debt / equityi | 224.47 | 96.82 |
| Interest coveragei | 2.03 | -5.42 |
| Revenue CAGR (3Y) %i | -- | -- |
| Net income CAGR (3Y) %i | -- | -- |
| FCF CAGR (3Y) %i | -- | -- |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| ROE %i | -- | -- | 2.06 | -7.12 |
| ROA %i | -- | -- | 0.76 | -0.79 |
| ROIC %i | -- | -- | 2.18 | -0.40 |
| 5-year avg ROE %i | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -2.84 | -3.33 |
| FCF / sales %i | -- | -- | -- | -- |
| Current ratioi | -- | -- | 1.97 | 2.40 |
| Quick ratioi | -- | -- | 1.71 | 1.82 |
| Debt / assetsi | -- | -- | 41.93 | 59.90 |
| LT debt / equityi | -- | -- | 110.81 | 527.68 |
| Interest coveragei | -- | -- | -1.62 | -3.86 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.
Accelevation Holdings discussion 0 comments